The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater

British Journal of Pharmacology

Volumn 99, Issue 1, 1990, Pages 202-206

  Buzzi, M G ^a   Moskowitz, M A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN I 125; BRADYKININ; CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; NEUROKININ A; SEROTONIN; SUBSTANCE P; SUMATRIPTAN; SUMATRIPTAN SUCCINATE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL; DURA MATER; EXTRAVASATION; GUINEA PIG; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIGRAINE; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; TRIGEMINAL NERVE;

EID: 0025103363     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1990.tb14679.x     Document Type: Article

References (24)

1. ALA‐HURULA, V., MYLLYLA, V.V., ARVELA, P., KARKI, N.T. & HOKKANEN, E. (1979). Systemic availability of ergotamine tartrate after three successive doses and during continuous medication. Eur. J. Clin. Pharmacol., 16, 355–360.
2. ANDRES, K.H., VON DURING, M., MUSZYNSKI, K. & SCHMIDT, R.F. (1987). Nerve fibers and their terminals of the dura mater encephali of the rat. Anat. Embryol. (Berl.), 175, 289–301.
3. ARMSTRONG, D., DRY, R., KEELE, C.A. & MARKHAM, J.W. (1953). Observation on chemical excitants of cutaneous pain in man. J. Physiol., 120, 326–351.
4. BRAIN, S.D., WILLIAMS, T.J., TIPPINS, J.R., MORRIS, H.R. & MACINTYRE, I. (1985). Calcitonin gene‐related peptide is a potent vasodilator. Nature, 313, 54–56.
5. BUZZI, M.G., SAKAS, D.E. & MOSKOWITZ, M.A. (1989). Indomethacin and acetylsalicyclic acid block neurogenic plasma protein extravasation in rat dura mater. Eur. J. Pharmacol., 165, 251–258.
6. DOENICKE, A., BRAND, J. & PERRIN, V.L. (1988). Possible benefit of GR43175, a novel 5‐HT 1 ‐like receptor agonist, for the acute treatment of severe migraine. Lancet, i, 1309–1311.
7. EDVINSSON, L. & UDDMAN, R. (1982). Immunohistochemical localization and dilatory effect of substance P on human cerebral vessels. Brain Res., 232, 466–471.
8. EKBOM, K., HARDEBO, J.H. & WALDENLIND, E. (1988). Mechanisms of cluster headache. In Basic Mechanisms of Headache. ed. Olesen, J. & Edvinsson, L. pp. 463–476. Amsterdam: Elsevier.
9. HARDEBO, J.E. (1984). The involvement of trigeminal substance P neurons in cluster headache. An hypothesis. Headache, 24, 294–304.
10. HUMPHREY, P.P.A., FENIUK, W., PERREN, M.J., CONNOR, H.E., OXFORD, A.W., COATES, L.H. & BUTINA, D. (1988). GR43175, a selective agonist for the 5‐HT 1 ‐like receptor in dog isolated saphenous vein. Br. J. Pharmacol., 94, 1123–1132.
11. JANSEN, I., UDDMAN, R., HOCHERMAN, M., EKMAN, R., JENSEN, K., OLESEN, J., STIERNHOLM, P. & EDVINSSON, L. (1986). Localization and effects of neuroptide Y, vasoactive intestinal polypeptide, substance P, and calcitonin gene‐related peptide in human temporal arteries. Ann. Neurol., 20, 496–501.
12. LEMBECK, F. & HOLZER, P. (1979). Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn-Schmiedebergs Arch. Pharmacol., 310, 175–183.
13. MARKOWITZ, S., SAITO, K. & MOSKOWITZ, M.A. (1987). Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J. Neurosci., 7, 4129–4136.
14. MAYBERG, M.R., LANGER, R.S., ZERVAS, N.T. & MOSKOWITZ, M.A. (1981). Perivascular meningeal projection from cat trigeminal ganglia: Possible pathway for vascular headache in man. Science, 213, 228–230.
15. MAYBERG, M.R., ZERVAS, N.T. & MOSKOWITZ, M.A. (1984). Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horseradish peroxidase histochemistry. J. Comp. Neurol., 223, 46–56.
16. MOSKOWITZ, M.A. (1984). The neurobiology of vascular head pain. Ann. Neurol., 16, 157–168.
17. MOSKOWITZ, M.A. (1986). Trigeminovascular connections and mechanisms of vascular headache. In Handbook of Clinical Neurology, 4 (48), Headache. ed. Rose, Clifford F. pp. 107–115. Amsterdam: Elsevier Science Publishers.
18. MOSKOWITZ, M.A., REINHARD, J.F., Jr, ROMERO, J., MELAMED, E. & PETTIBONE, F.J. (1979). Neurotransmitters and the fifth cranial nerve: Is there a relation to the headache phase of migraine? Lancet, ii, 883–885.
19. OLSEN, T.S. & OLESEN, J. (1988). Regional cerebral blood flow in migraine and cluster headache. In Basic Mechanisms of Headache. ed. Olesen, J. & Edvinsson, L. pp. 377–391. Amsterdam: Elsevier.
20. RAY, B.S. & WOLFF, H.G. (1940). Experimental studies on headache. Pain sensitive structures of the head and their significance in headache. Arch. Surg., 41, 813–856.
21. SAITO, K., GREENBERG, S. & MOSKOWITZ, M.A. (1987). Trigeminal origin of beta‐preprotachykinin products in feline pial blood vessels. Neurosci. Lett., 76, 69–73.
22. SAITO, K., MARKOWITZ, S. & MOSKOWITZ, M.A. (1988). Ergot alkaloids block neurogenic extravasation in dura mater: Proposed action in vascular headache. Ann. Neurol., 24, 732–737.
23. SARIA, A., GAMSE, R., LUNDBERG, J.M., HOKFELT, T., THEODORSSON‐NORHEIM, E., PETERMANN, J. & FISCHER, J.A. (1985). Co‐existence of tachykinins and calcitonin gene‐related peptide in sensory nerves in relation to neurogenic inflammation. In Tachykinin Antagonists. ed. Hakanson, R. & Sundler, F. Amsterdam: Elsevier.
24. SARIA, A., GAMSE, R., PETERMAN, J., FISCHER, J.A., THEODORSSON‐NORHEIM, E. & LUNDBERG, J.M. (1986). Simultaneous release of several tachykinins and calcitonin gene‐related peptide from rat spinal cord slices. Neurosci. Lett., 63, 310–314.